(29) reported that ERAP2 rs2248374/rs2549782-AG haplotype was significantly associated with increased NSCLC risk, while ERAP2 rs2248374/rs2549782-GT haplotype individuals tended to indicate a reduced risk. Here, ERAP2 is linked to non-small cell lung carcinoma.